Biomarker-based asthma phenotypes of corticosteroid response.

[1]  N. Wilson,et al.  Longitudinal relationship between sputum eosinophils and exhaled nitric oxide in children with asthma. , 2013, American journal of respiratory and critical care medicine.

[2]  Sandy Jung-Wu.  Urinary Bromotyrosine Measures Asthma Control and Predicts Asthma Exacerbations in Children , 2012, Pediatrics.

[3]  A. Bush,et al.  Use of sputum eosinophil counts to guide management in children with severe asthma , 2012, Thorax.

[4]  S. Wenzel,et al.  Asthma outcomes: biomarkers. , 2012, The Journal of allergy and clinical immunology.

[5]  M. Wegmann.  Targeting eosinophil biology in asthma therapy. , 2011, American journal of respiratory cell and molecular biology.

[6]  W. Busse,et al.  Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. , 2010, American journal of respiratory and critical care medicine.

[7]  G. Roberts,et al.  Influence of atopy and asthma on exhaled nitric oxide in an unselected birth cohort study , 2010, Thorax.

[8]  S. Willsie.  Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma , 2010 .

[9]  J. Cowan,et al.  Effects of steroid therapy on inflammatory cell subtypes in asthma , 2009, Thorax.

[10]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[11]  E. Israel,et al.  Noninvasive Markers of Airway Inflammation in Asthma , 2009, Clinical and translational science.

[12]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[13]  J. L. Puckett,et al.  Partitioned exhaled nitric oxide to non-invasively assess asthma , 2008, Respiratory Physiology & Neurobiology.

[14]  A. Michils,et al.  Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients , 2008, European Respiratory Journal.

[15]  C. Lemière,et al.  Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. , 2006, The Journal of allergy and clinical immunology.

[16]  P. Paggiaro,et al.  Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients. , 2006, Chest.

[17]  G. Heldt,et al.  Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. , 2006, The Journal of allergy and clinical immunology.

[18]  I. Pavord,et al.  The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  Klas Svensson,et al.  Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. , 2005, Respiratory medicine.

[20]  E. Israel,et al.  Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. , 2005, The Journal of allergy and clinical immunology.

[21]  D. Knight,et al.  Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath , 2004, Thorax.

[22]  I. Pavord,et al.  Comparison of airway immunopathology of eosinophilic bronchitis and asthma , 2003, Thorax.

[23]  S. Anderson,et al.  Methods for “Indirect” challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols , 2003, Clinical reviews in allergy & immunology.

[24]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[25]  M. Segal,et al.  Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. , 2001, The Journal of allergy and clinical immunology.

[26]  R. Hancox,et al.  The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. , 2001, American journal of respiratory and critical care medicine.

[27]  S. Hazen,et al.  Eosinophils Are a Major Source of Nitric Oxide-Derived Oxidants in Severe Asthma: Characterization of Pathways Available to Eosinophils for Generating Reactive Nitrogen Species4 , 2001, The Journal of Immunology.

[28]  R. Dweik,et al.  NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  C. Jenkins,et al.  Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. , 2001, American journal of respiratory and critical care medicine.

[30]  E. Bacci,et al.  Analysis of induced sputum before and after withdrawal of treatment with inhaled corticosteroids in asthmatic patients , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  S. Hazen,et al.  Eosinophils generate brominating oxidants in allergen-induced asthma. , 2000, The Journal of clinical investigation.

[32]  P. Barnes,et al.  Changes in sputum eosinophils predict loss of asthma control. , 2000, American journal of respiratory and critical care medicine.

[33]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[34]  I. Pavord,et al.  Non-eosinophilic cor ticosteroid unresponsive asthma , 1999, The Lancet.

[35]  K. Chung,et al.  Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. , 1998, Thorax.

[36]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[37]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[38]  H. Boushey,et al.  Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. , 1993, The American review of respiratory disease.

[39]  S. Holgate,et al.  The effect of inhaled ipratropium bromide alone and in combination with oral terfenadine on bronchoconstriction provoked by adenosine 5'-monophosphate and histamine in asthma. , 1991, The Journal of allergy and clinical immunology.

[40]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[41]  H. Brown.  Treatment of chronic asthma with prednisolone; significance of eosinophils in the sputum. , 1958, Lancet.